Insulin protects apoptotic cardiomyocytes from hypoxia/reoxygenation injury through the sphingosine kinase/sphingosine 1-phosphate axis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Yu, Huan ^a,b   Che, Xiangxin ^a,b   Xu, Xiaoyuan ^a,b   Zheng, Meirong ^a   Zhao, Yong ^a   He, Wei ^a   Yu, Jingmou ^a,b   Xiong, Jianjun ^a,b   Li, Weidong ^b  

^a JIUJIANG UNIVERSITY   (China)

^b Key Laboratory of Jiangxi for the Systems Bio medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LOCALIZATION; HEART MUSCLE CELL; HEART PROTECTION; NONHUMAN; RAT; REOXYGENATION; REPERFUSION INJURY;

ANIMALS; CELL HYPOXIA; CELLS, CULTURED; IN SITU NICK-END LABELING; INSULIN; LYSOPHOSPHOLIPIDS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE;

EID: 84892610332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080644     Document Type: Article

References (32)

1. Piper HM, Abdallah Y, Schafer C (2004) The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61: 365-371.
2. Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357: 1121-1135.
3. Sodi-Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, et al. (1962) Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 9: 166-181.
4. Jonassen AK, Brar BK, Mjos OD, Sack MN, Latchman DS, et al. (2000) Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 32: 757-764.
5. Gao F, Tao L, Yan W, Gao E, Liu HR, et al. (2004) Early anti-apoptosis treatment reduces myocardial infarct size after a prolonged reperfusion. Apoptosis 9: 553-559.
6. Jonassen AK, Mjos OD, Sack MN (2004) p70s6 kinase is a functional target of insulin activated Akt cell-survival signaling. Biochem Biophys Res Commun 315: 160-165.
7. Ma H, Zhang HF, Yu L, Zhang QJ, Li J, et al. (2006) Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production. Cardiovasc Res 69: 57-65.
8. Zaha V, Francischetti I, Doenst T (2003) Insulin improves postischemic recovery of function through PI3K in isolated working rat heart. Mol Cell Biochem 247: 229-232.
9. Fu J, Huang H, Liu J, Pi R, Chen J, et al. (2007) Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 568: 213-221.
10. Song JQ, Teng X, Cai Y, Tang CS, Qi YF (2009) Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis 14: 1299-1307.
11. Jonassen AK, Brar BK, Mjos OD, Sack MN, Latchman DS, et al. (2000) Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 32: 757-764.
12. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, et al. (2002) Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105: 1497-1502.
13. Lebman DA, Spiegel S (2008) Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. J Lipid Res 49: 1388-1394.
14. Karliner JS, Honbo N, Summers K, Gray MO, Goetzl EJ (2001) The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol 33: 1713-1717.
15. Tao R, Hoover HE, Honbo N, Kalinowski M, Alano CC, et al. (2010) Highdensity lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol 298: H1022-H1028.
16. Jin ZQ, Goetzl EJ, Karliner JS (2004) Sphingosine kinase activation mediates ischemic preconditioning in murine heart. Circulation 110: 1980-1989.
17. Karliner JS (2009) Sphingosine kinase and sphingosine 1-phosphate in cardioprotection. J Cardiovasc Pharmacol 53: 189-197.
18. Palanivel R, Fang X, Park M, Eguchi M, Pallan S, et al. (2007) Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes. Cardiovasc Res 75: 148-157.
19. Kajimoto T, Okada T, Yu H, Goparaju SK, Jahangeer S, et al. (2007) Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. Mol Cell Biol 27: 3429-3440.
20. Olivera A, Barlow KD, Spiegel S (2000) Assaying sphingosine kinase activity. Methods Enzymol 311: 215-223.
21. Siow DL, Wattenberg BW (2007) An assay system for measuring the acute production of sphingosine 1-phosphate in intact monolayers. Anal Biochem 371: 184-193.
22. Bastiaens PI, Majoul IV, Verveer PJ, Soling HD, Jovin TM (1996) Imaging the intracellular trafficking and state of the AB5 quaternary structure of cholera toxin. EMBO J 15: 4246-4253.
23. Liu J, Ernst SA, Gladycheva SE, Lee YY, Lentz SI, et al. (2004) Fluorescence resonance energy transfer reports properties of syntaxin1a interaction with Munc18-1 in vivo. J Biol Chem 279: 55924-55936.
24. Krasel C, Bunemann M, Lorenz K, Lohse MJ (2005) Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem 280: 9528-9535.
25. Semple DJ, Bhandari S, Seymour AM (2012) Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin. Am J Physiol Renal Physiol 303: F1275-F1286.
26. Engbersen R, Riksen NP, Mol MJ, Bravenboer B, Boerman OC, et al. (2012) Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study. Cardiovasc Diabetol 11: 124.
27. Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, et al. (2007) Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circ Res 100: 41-49.
28. Limaye V, Li X, Hahn C, Xia P, Berndt MC, et al. (2005) Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood 105: 3169-3177.
29. Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, et al. (2002) Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol 282: H1970-H1977.
30. Knapp M (2011) Cardioprotective role of sphingosine-1-phosphate. J Physiol Pharmacol 62: 601-607.
31. Means CK, Xiao CY, Li Z, Zhang T, Omens JH, et al. (2007) Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 292: H2944-H2951.
32. Means CK, Brown JH (2009) Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc Res 82: 193-200.